Improvement of matched sibling donor engraftment with sirolimus added to a non-myeloablative conditioning regimen

被引：0
|
作者：
Claxton, DF [1 ]
Ehmann, C [1 ]
Shaffer, M [1 ]
Rybka, W [1 ]
机构：
[1] Penn State Coll Med, Hershey, PA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2005年 / 11卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2004.12.071
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
71
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [31] Graft-versus-host disease (GVHD) after non-myeloablative (NMA) versus myeloablative (MA) conditioning regimens in fully matched sibling donor hematopoietic stem cell transplants (HSCT): An update.
    Couriel, DR
    Khouri, IF
    Andersson, B
    Cohen, A
    Saliba, R
    DeLima, M
    Martin, T
    Giralt, S
    Champlin, R
    BLOOD, 2001, 98 (11) : 404A - 404A
  • [32] Non-myeloablative matched sibling donor peripheral blood stem cell transplant is curative for human heme-oxygenase-1 deficiency
    Yadav, Satya Prakash
    Nivargi, Sagar
    Sharma, Anil
    Thakkar, Dhwanee
    Rastogi, Neha
    BONE MARROW TRANSPLANTATION, 2019, 54 : 388 - 388
  • [33] Non-myeloablative conditioning regimen in patients with high risk acute myeloid leukemia:: unrelated and sibling allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
    Basara, N
    Roemer, E
    Günzelmann, S
    Schmetzer, B
    Fauser, AA
    Kiehl, MG
    BONE MARROW TRANSPLANTATION, 2001, 27 : S86 - S86
  • [34] Durable engraftment of mismatched unrelated cord blood following a non-myeloablative preparative regimen for adults.
    Rizzieri, DA
    Long, GD
    Vredenburgh, JJ
    Gasparetto, C
    Morris, A
    Niedzwiecki, D
    Lassiter, M
    Loftis, J
    Davis, P
    McDonald, C
    Stenzel, T
    Waters-Pick, B
    Kurtzberg, J
    Chao, NJ
    BLOOD, 2001, 98 (11) : 185A - 185A
  • [35] Unrelated and sibling allogeneic hematopoietic stem cell transplantation (HSCT) in patients with advanced hematological malignancies by using non-myeloablative conditioning regimen.
    Roemer, E
    Kiehl, MG
    Guenzelmann, S
    Rajewski, A
    Kirsten, D
    Fauser, AA
    Basara, N
    BLOOD, 2000, 96 (11) : 782A - 782A
  • [36] Perivascular, but not parenchymal, cerebral engraftment of donor cells after non-myeloablative bone marrow transplantation
    Yang, Yue
    Jorstad, Nikolas L.
    Shiao, Christine
    Cherne, Makenzie K.
    Khademi, Shawn B.
    Montine, Kathleen S.
    Montine, Thomas J.
    Keene, C. Dirk
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 95 (01) : 7 - 17
  • [37] Sirolimus and tacrolimus allow engraftment of haploidentical and other alternative donor stem cells after now myeloablative conditioning
    Claxton, DF
    Popescu, D
    Carraher, M
    Chiafari, FA
    Ehmann, C
    Rybka, W
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2004, 10 (02) : 38 - 39
  • [38] Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS
    Robin, M.
    Porcher, R.
    Ades, L.
    Boissel, N.
    Raffoux, E.
    Xhaard, A.
    Larghero, J.
    Gardin, C.
    Himberlin, C.
    Delmer, A.
    Fenaux, P.
    Dombret, H.
    Socie, G.
    de latour, R. Peffault
    BONE MARROW TRANSPLANTATION, 2013, 48 (10) : 1296 - 1301
  • [39] Non-myeloablative conditioning regimen for allogeneic stem cell transplantation in patients with advanced hematological malignancies
    Malesevic, M
    Stamatovic, D
    Tukic, L
    Marjanovic, S
    Balint, B
    Tarabar, O
    Todoric, B
    Ristic, L
    Milicevic, S
    BONE MARROW TRANSPLANTATION, 2001, 27 : S294 - S295
  • [40] Matched unrelated or matched sibling donors result in comparable outcomes after non-myeloablative HSCT in patients with AML or MDS
    M Robin
    R Porcher
    L Adès
    N Boissel
    E Raffoux
    A Xhaard
    J Larghero
    C Gardin
    C Himberlin
    A Delmer
    P Fenaux
    H Dombret
    G Socié
    R Peffault de Latour
    Bone Marrow Transplantation, 2013, 48 : 1296 - 1301
12345